Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation TCT India 2025

Hybrid PCI-Less Metal More Medicine

Presenter: Sanjeev Gera

July 26, 2025

Presentation TCT India 2025

Hybrid approach to Complex PCI

Presenter: Sandeep Parekh

July 26, 2025

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

Presentation JIM 2018

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

Presenter: Luca Testa

February 22, 2018

Presentation JIM 2018

“Cre8TM EVO: Establishing a new DES benchmark for diabetic patients”

Presenter: Gennaro Sardella

February 22, 2018

Presentation EuroPCR 2017

BIO-RESORT Silent Diabetes

Presenter: Clemens von Birgelen

May 19, 2017

Presentation JIM 2017

Dedicated Designed DES+ for Diabetic Patients

Presenter: Dinesh Shah

February 10, 2017

Presentation

Efficacy and Safety of the Absorb Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Absorb Diabetic Substudy

Presenter: D. Kereiakes

December 23, 2016

Presentation

PCI in Patients With Insulin-Treated andNon-Insulin-Treated Diabetes Mellitus

Presenter: Sripal Bangalore

April 22, 2016

Presentation

Impact of Diabetes on Outcomes After PCI With DES in Relation to CAD Complexity

Presenter: KC. Koskinas

February 02, 2016

Presentation

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

Presenter: Jens Wiebe

August 26, 2015

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

Presentation

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Presenter: Mohamed Abdel-Wahab

July 23, 2015

Presentation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Presenter: K.K.W. Olesen

November 13, 2014

Presentation TCT 2014

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Upendra Kaul

September 14, 2014

Presentation BRS 2014

The Bioresorbable Scaffold BRS in Diabetes

Presenter: Antonio L. Bartorelli

July 26, 2014

Presentation

Impact of Coronary Lesion Complexity on DES Outcomes in Patients with and Without Diabetes

Presenter: E. Kedhi

March 12, 2014

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Presenter: Elvin Kedhi

October 29, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Advertisement

Hybrid PCI-Less Metal More Medicine

Hybrid approach to Complex PCI

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

A New Generation Abluminal Coated Sirolimus Eluting Stent As A Treatment Option For Diabetic Patients

“Cre8TM EVO: Establishing a new DES benchmark for diabetic patients”

BIO-RESORT Silent Diabetes

Dedicated Designed DES+ for Diabetic Patients

Efficacy and Safety of the Absorb Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Absorb Diabetic Substudy

PCI in Patients With Insulin-Treated andNon-Insulin-Treated Diabetes Mellitus

Impact of Diabetes on Outcomes After PCI With DES in Relation to CAD Complexity

Implantation of Everolimus-Eluting Bioresorbable Scaffolds in a Diabetic All-Comers Population

EES vs CABG for Patients With Diabetes and Multivessel Disease

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

The Bioresorbable Scaffold BRS in Diabetes

Impact of Coronary Lesion Complexity on DES Outcomes in Patients with and Without Diabetes

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content